Induction of an antibody response in mice against human papillomavirus (HPV) type 16 after immunization with HPV recombinant Salmonella strains.
Human papillomaviruses (HPV) are present in approximately 95% of all cervical carcinomas and the HPV E6 and E7 genes are continuously expressed in these lesions. There is also circumstantial evidence that often natural immunity against HPV is generated and that this is of influence on HPV-induced lesions. Stimulation of the immune system by proper presentation of relevant HPV antigens might, therefore, lead to a prophylactic or therapeutic immunological intervention for HPV-induced lesions. For this purpose we have expressed the E6 and E7 protein of HPV 16 in an attenuated strain of Salmonella typhimurium (SL3261, aroA mutation), which has been used extensively as a live vector. Live recombinant Salmonella vaccines have the ability to elicit humoral, secretory and cell-mediated immune responses, including cytotoxic T cells, against the heterologous antigens they express. This report describes the construction of recombinant Salmonella strains expressing the HPV 16 E6 and E7 proteins, and the induction of an HPV-16-specific immune response in mice after immunization with these live vectors.
Krul
M R
MR
European Cancer Centre, Amsterdam, The Netherlands. ecc@euronet.nl
Tijhaar
E J
EJ
Kleijne
J A
JA
Van Loon
A M
AM
Nievers
M G
MG
Schipper
H
H
Geerse
L
L
Van der Kolk
M
M
Steerenberg
P A
PA
Mooi
F R
FR
Den Otter
W
W
D000914:Antibodies, Viral / Q000276:immunology; D000917:Antibody Formation; D001428:Bacterial Vaccines / Q000276:immunology*; D005814:Genes, Viral / Q000276:immunology; D027383:Papillomaviridae / Q000276:immunology*; D011994:Recombinant Proteins / Q000276:immunology; D011995:Recombination, Genetic; D012480:Salmonella Infections / Q000276:immunology / Q000517:prevention & control; D012483:Salmonella Phages / Q000276:immunology; D012486:Salmonella typhimurium / Q000235:genetics / Q000821:virology; D014614:Vaccines, Synthetic / Q000276:immunology*
D000914:Antibodies, Viral; D001428:Bacterial Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic